Condition: Locally Advanced Pancreatic Cancer · Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
The Objectives of this clinical trial is to evaluate the efficacy and safety of tumor treating fields combined with gemcitabine and albumin bound paclitaxel in the treatment of locally advanced pancreatic cancer.
This description comes directly from the study's public registry record.
Fu · 021-52889999 · Surgeonfu@163.com
Always discuss trial participation with your own doctor first.
| Harbin Medical University Cancer Hospital | Harbin, Heilongjiang, China | Recruiting |
| Cancer Hospital of Shandong First Medical University | Jinan, Shandong, China | Recruiting |
| Fudan University Shanghai Cancer Center | Shanghai, Shanghai Municipality, China | Recruiting |
| Fudan University Affiliated Huashan Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Huashan Hospital Affiliated to Fudan University | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05653453